Active Ingredient: GLYCOPYRROLATE
Proprietary Name: DARTISLA ODT
Dosage Form; Route of Administration: TABLET, ORALLY DISINTEGRATING; ORAL
Strength: 0.85MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N215019
Product Number: 002
Approval Date: Oct 11, 2023
Applicant Holder Full Name: EDENBRIDGE PHARMACEUTICALS LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
